Tenax Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview

Tenax Therapeutics

13/05/2023 02:39

* Tenax Therapeutics Inc  TENX.OQ   TENX.O  is expected
to report
results on May 15 (estimated).
    * 
    * ​Refinitiv's mean analyst estimate for Tenax Therapeutics
Inc is
for a loss of 37 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts had fallen by
about 34.1%
in the last three months. ​
    * Wall Street's median 12-month price target for Tenax
Therapeutics Inc is $5.5​, above​ its last closing price
of $0.36. ​​​

This summary was machine generated May 13 at 01:39 GMT.  All
figures in US dollars  unless otherwise stated